IFABOTUZUMAB
UNII 2BN89552WP

Substance Identification & Data

This profile provides standardized clinical and technical data for Ifabotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2BN89552WP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1234137-51-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2BN89552WP
CAS Registry Number
1234137-51-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IFABOTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10149
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
DE-43
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ifabotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FIBATUZUMAB
IFABOTUZUMAB

Common Names & Synonyms

IFABOTUZUMAB [INN]
IFABOTUZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPHA RECEPTOR EPHA3) (HUMAN MONOCLONAL KB004 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL KB004 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EPHA3(EPHRIN RECEPTOR A3, EPH RECEPTOR A3, EPHRIN TYPE-A RECEPTOR 3, TYROSINE PROTEIN KINASE TYR04, TYROSINE-PROTEIN KINASE RECEPTOR REK4, ETK, ETK1, HEK, HEK4)), HUMANIZED MONOCLONAL ANTIBODY